Study S001766

A Phase 2, Prospective, Randomized, Multicenter, Open-Label, Controlled Trial to Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation.

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT03961256
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 9
Start: 2019-05-09
Primary completion: 2021-10-18
Lead sponsor: Mayo Clinic
Conditions: Pre Diabetes
Interventions: DRUG:Exenatide SR
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Progression From Prediabetes to Diabetes [12 months after transplantation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.